<DOC>
	<DOCNO>NCT00548067</DOCNO>
	<brief_summary>The purpose study determine potential pharmacokinetic drug-drug interaction three drug ( valsartan , amlodipine , hydrochlorothiazide ) co-administered .</brief_summary>
	<brief_title>Pharmacokinetic Drug Interaction Study Following Co-administration Valsartan , Hydrochlorothiazide Amlodipine Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients diagnose hypertensive Untreated confirm hypertensive patient ( consistent SBP &gt; 140 mm Hg DBP &gt; 90 mm Hg ) Uncontrolled hypertensive patient ( Consistent SBP &gt; 140 mm Hg DBP &gt; 90 mm Hg ) one drug therapy . Uncontrolled hypertensive patient ( Consistent SBP &gt; 140 mm Hg DBP &gt; 90 mm Hg ) two drug therapy . Inability switch prior antihypertensive medication safely require protocol . Need drug study drug time baseline . Patients SBP ≥ 180 mmHg and/or DBP ≥ 110 mmHg screening . Patients four antihypertensive drug screen . Pregnant nursing ( lactate ) woman . Patients diabetes mellitus Patients heart diseases disease Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>High blood pressure , hypertension , drug interaction , steady state , valsartan , hydrochlorothiazide , amlodipine</keyword>
</DOC>